Skip to content

Evaluate the effect of Laxmivilas Rasa and Madhyam Narayan Taila Karnapuran in the management of Conductive Hearing Loss and Sensorineural Hearing Loss.

A comparative study to evaluate the effect of Laxmivilas Rasa and Madhyam Narayan Taila Karnapuran in the management of Conductive Hearing Loss and Sensorineural Hearing Loss. - NIl

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080803
Enrollment
30
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H60-H95- Diseases of the ear and mastoid process

Interventions

None listed

Sponsors

Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing and able to participate in the trial. Patient presenting with signs and Symptoms of sensorineural and conductive hearing loss Patients of above 5years and below 60 years age will be selected.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the trial. Patients suffering from other ear pathologies like tumours, trauma of External Auditory Canal etc. Patients above 60 years and below 5 years old. Patient suffering from malnutrition.

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptoms of Conductive and Sensorineural Hearing Loss in patientTimepoint: 30 days

Secondary

MeasureTime frame
To study the the clinical safety of Laxmivilas Rasa and Madhyam Narayan Taila in the management of Conductive Hearing loss and Sensorineural Hearing Loss.Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Nihar Jetly

Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola

bhardwajvijayant@gmail.com9418017568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026